Emil Davidovich Isagulyan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Emil Davidovich Isagulyan has a total of 143 co-authors. Here are the top co-authors by number of shared publications:
- Аleksey A. Tomskiy
N.N. Burdenko National Medcial Research Center of Neurosurgery Moscow Russia
11 shared publications - Andrey V. Dekopov
Burdenko Neurosurgical Center
6 shared publications - Viktor P. Kondratyev
Burdenko Neurosurgical Center
6 shared publications - Karina Aslakhanova
Burdenko Neurosurgical Center
4 shared publications - Pavel G. Genov
Department for the Treatment of Patients with Chronic Pain Syndromes, Moscow Clinical Research Center Hospital No. 52
4 shared publications - D. E. Semenov
Burdenko Neurosurgery Center, Moscow, Russian Federation
3 shared publications
Latest Publications
- Open Access
- 25 August 2026
- Published by ECO-Vector LLC (Publications) in N.N. Priorov Journal of Traumatology and Orthopedics
- Vol. 33 (3) , 724-733
Sciatic nerve stimulation for post-traumatic sciatic neuropathy: a systematic review
Post-traumatic sciatic neuropathy is a common and severe condition that is often resistant to standard treatments, including conservative therapy and surgical neurolysis. Chronic peripheral nerve stimulation has emerged as a promising treatment aimed at pain relief and potential functional recovery. Despite the clinical importance of this problem and growing interest in the technique, consolidated data on the efficacy of sciatic nerve stimulation are lacking. We conducted a systematic review according to PRISMA guidelines of original studies published over the last 10 years. Searches were performed in PubMed, Google Scholar, and eLibrary. Seven studies evaluating direct sciatic nerve stimulation in patients with post-traumatic neuropathy met the inclusion criteria. The analysis focused on pain dynamics (Visual Analog Scale) and functional recovery indicators (Medical Research Council scale, Oswestry Disability Index, and others). The results demonstrated a statistically and clinically significant reduction in pain severity in stimulation groups compared with controls. Pain reduction ranged from 43% to 86%. However, data on muscle strength recovery were limited; most studies relied on indirect functional scales or had insufficient follow-up to adequately assess motor function. Significant methodological heterogeneity among the included studies — including differences in study design, stimulation protocols, and outcome measures — precluded meta-analysis. The available evidence strongly supports the efficacy of chronic sciatic nerve stimulation for pain reduction in post-traumatic neuropathy. At the same time, further research is needed to evaluate its impact on motor function recovery and to define its role in treatment algorithms. Priority should be given to randomized controlled trials directly comparing stimulation with neurolysis and assessing long-term outcomes.
- 25 August 2026
- Published by ECO-Vector LLC (Publications) in N.N. Priorov Journal of Traumatology and Orthopedics
- Vol. 33 (3) , 724-733
Open AccessSciatic nerve stimulation for post-traumatic sciatic neuropathy: a systematic review
Post-traumatic sciatic neuropathy is a common and severe condition that is often resistant to standard treatments, including conservative therapy and surgical neurolysis. Chronic peripheral nerve stimulation has emerged as a promising treatment aimed at pain relief and potential functional recovery. Despite the clinical importance of this problem and growing interest in the technique, consolidated data on the efficacy of sciatic nerve stimulation are lacking. We conducted a systematic review according to PRISMA guidelines of original studies published over the last 10 years. Searches were performed in PubMed, Google Scholar, and eLibrary. Seven studies evaluating direct sciatic nerve stimulation in patients with post-traumatic neuropathy met the inclusion criteria. The analysis focused on pain dynamics (Visual Analog Scale) and functional recovery indicators (Medical Research Council scale, Oswestry Disability Index, and others). The results demonstrated a statistically and clinically significant reduction in pain severity in stimulation groups compared with controls. Pain reduction ranged from 43% to 86%. However, data on muscle strength recovery were limited; most studies relied on indirect functional scales or had insufficient follow-up to adequately assess motor function. Significant methodological heterogeneity among the included studies — including differences in study design, stimulation protocols, and outcome measures — precluded meta-analysis. The available evidence strongly supports the efficacy of chronic sciatic nerve stimulation for pain reduction in post-traumatic neuropathy. At the same time, further research is needed to evaluate its impact on motor function recovery and to define its role in treatment algorithms. Priority should be given to randomized controlled trials directly comparing stimulation with neurolysis and assessing long-term outcomes.
- 20 June 2026
- Published by IMA Press, LLC in Neurology, Neuropsychiatry, Psychosomatics
- Vol. 18 (3)
The use of botulinum toxin type A in the treatment of chronic drug-resistant pain in a patient with type 1 neurofibromatosis
Chronic pain remains one of the most challenging issues in the management of patients with type 1 neurofibromatosis (NF1), significantly reducing their quality of life. The aetiology of pain in NF1 is multifactorial and not fully understood, which complicates the selection of effective treatment. Current treatment methods – pharmacotherapy, surgical removal of tumours and neuromodulation – do not always provide a lasting analgesic effect and are associated with a risk of complications or recurrence of pain. The clinical case presented demonstrates the successful treatment of severe, drug-resistant pain syndrome in a patient with NF1 using botulinum toxin type A (incobotulinumtoxin). The use of botulinum toxin type A under ultrasound guidance resulted in a significant reduction in pain intensity, a decrease in the frequency of pain episodes, and an improvement in the patient’s quality of life, with no adverse events. Thus, we report for the first time the use of incobotulinumtoxin in NF1 with a positive clinical outcome.
- 20 June 2026
- Published by IMA Press, LLC in Neurology, Neuropsychiatry, Psychosomatics
- Vol. 18 (3)
The use of botulinum toxin type A in the treatment of chronic drug-resistant pain in a patient with type 1 neurofibromatosis
Chronic pain remains one of the most challenging issues in the management of patients with type 1 neurofibromatosis (NF1), significantly reducing their quality of life. The aetiology of pain in NF1 is multifactorial and not fully understood, which complicates the selection of effective treatment. Current treatment methods – pharmacotherapy, surgical removal of tumours and neuromodulation – do not always provide a lasting analgesic effect and are associated with a risk of complications or recurrence of pain. The clinical case presented demonstrates the successful treatment of severe, drug-resistant pain syndrome in a patient with NF1 using botulinum toxin type A (incobotulinumtoxin). The use of botulinum toxin type A under ultrasound guidance resulted in a significant reduction in pain intensity, a decrease in the frequency of pain episodes, and an improvement in the patient’s quality of life, with no adverse events. Thus, we report for the first time the use of incobotulinumtoxin in NF1 with a positive clinical outcome.
- 25 May 2026
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 90 (3) , 67-72
Chronic epidural electrical stimulation of lumbar enlargement for pain relief after ineffective neurolysis in patients with post-traumatic sciatic neuropathy
Introduction. Peripheral nerveinjuries affect approximately 200.000 patients annually in Russia, and sciatic nerve injuries constitute about 8.3% (~16.600 cases). Many patients develop chronic neuropathic pain refractory to standard therapy. Surgical neurolysis provides adequate relief in only 50—80% of cases, and effective alternatives are needed for other patients. Chronic spinal cord stimulation (SCS) is a promising modality for these patients. Objective. To evaluate efficacy and safety of chronic SCS for chronic pain due to post-traumatic sciatic neuropathy refractory to conservative therapy and neurolysis. Material and methods. A retrospective single-center study included 10 patients with persistent neuropathic pain despite prior pharmacotherapy and neurolysis. All patients underwent SCS with pain assessment. The primary efficacy criterion was reduction of VAS score ≥50% after test stimulation period. Results. Positive responses were achieved in 9 out of 10 patients (90%). Mean VAS scores significantly decreased from 7.9±1.3 to 3.3±1.5 (p=0.007). Therapeutic effect was maintained in all responders throughout the follow-up period (3 months-2 years) without complications. Conclusion. Chronic SCS is a highly effective and safe treatment for chronic pain in patients with post-traumatic sciatic neuropathy resistant to standard therapies. These results justify SCS in such clinical scenarios and highlight the need for further prospective studies.
- 25 May 2026
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 90 (3) , 67-72
Chronic epidural electrical stimulation of lumbar enlargement for pain relief after ineffective neurolysis in patients with post-traumatic sciatic neuropathy
Introduction. Peripheral nerveinjuries affect approximately 200.000 patients annually in Russia, and sciatic nerve injuries constitute about 8.3% (~16.600 cases). Many patients develop chronic neuropathic pain refractory to standard therapy. Surgical neurolysis provides adequate relief in only 50—80% of cases, and effective alternatives are needed for other patients. Chronic spinal cord stimulation (SCS) is a promising modality for these patients. Objective. To evaluate efficacy and safety of chronic SCS for chronic pain due to post-traumatic sciatic neuropathy refractory to conservative therapy and neurolysis. Material and methods. A retrospective single-center study included 10 patients with persistent neuropathic pain despite prior pharmacotherapy and neurolysis. All patients underwent SCS with pain assessment. The primary efficacy criterion was reduction of VAS score ≥50% after test stimulation period. Results. Positive responses were achieved in 9 out of 10 patients (90%). Mean VAS scores significantly decreased from 7.9±1.3 to 3.3±1.5 (p=0.007). Therapeutic effect was maintained in all responders throughout the follow-up period (3 months-2 years) without complications. Conclusion. Chronic SCS is a highly effective and safe treatment for chronic pain in patients with post-traumatic sciatic neuropathy resistant to standard therapies. These results justify SCS in such clinical scenarios and highlight the need for further prospective studies.
- 27 November 2025
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 89 (6) , 62-68
Chronic electrical stimulation in patients with traumatic sciatic neuropathy
Objective. To evaluate the effectiveness of neurolysis combined with chronic electrical stimulation in patients with post-traumatic sciatic neuropathy. Material and methods. A prospective randomized study enrolled 14 patients with post-traumatic sciatic neuropathy. Patients were divided into two groups: group A (neurolysis+chronic electrical stimulation) and group B (neurolysis). Group A included 6 patients. All ones had severe neurogenic pain syndrome (VAS score 7.16±0.75). In five patients, pain syndrome was accompanied by muscle weakness. Group B included 8 patients with severe neurogenic pain syndrome (VAS score 7.42±0.78). Muscle weakness was noted in seven cases. We assessed pain and muscle strength before surgery, in early postoperative period, 3, 6 and 12 months after surgery. Results. In group A, pain decreased in all cases (from 7.16±0.75 points before surgery to 2.33±1.36 points after 12 months). All patients with muscle weakness experienced higher muscle strength and range of voluntary movements after 12 months. In group B, pain decreased only in 4 out of 8 patients. Dynamics of pain ranged from 7.42±0.78 points before surgery to 5±3.02 points after 12 months. Higher muscle strength and range of movements were observed in only two patients. Conclusion. Neurolysis combined with chronic electrical stimulation is followed by better outcomes in patients with post-traumatic sciatic neuropathy. Chronic peripheral electrical stimulation probably has an effect on recovery of motor functions.
- 27 November 2025
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 89 (6) , 62-68
Chronic electrical stimulation in patients with traumatic sciatic neuropathy
Objective. To evaluate the effectiveness of neurolysis combined with chronic electrical stimulation in patients with post-traumatic sciatic neuropathy. Material and methods. A prospective randomized study enrolled 14 patients with post-traumatic sciatic neuropathy. Patients were divided into two groups: group A (neurolysis+chronic electrical stimulation) and group B (neurolysis). Group A included 6 patients. All ones had severe neurogenic pain syndrome (VAS score 7.16±0.75). In five patients, pain syndrome was accompanied by muscle weakness. Group B included 8 patients with severe neurogenic pain syndrome (VAS score 7.42±0.78). Muscle weakness was noted in seven cases. We assessed pain and muscle strength before surgery, in early postoperative period, 3, 6 and 12 months after surgery. Results. In group A, pain decreased in all cases (from 7.16±0.75 points before surgery to 2.33±1.36 points after 12 months). All patients with muscle weakness experienced higher muscle strength and range of voluntary movements after 12 months. In group B, pain decreased only in 4 out of 8 patients. Dynamics of pain ranged from 7.42±0.78 points before surgery to 5±3.02 points after 12 months. Higher muscle strength and range of movements were observed in only two patients. Conclusion. Neurolysis combined with chronic electrical stimulation is followed by better outcomes in patients with post-traumatic sciatic neuropathy. Chronic peripheral electrical stimulation probably has an effect on recovery of motor functions.
- 15 October 2025
- Published by Wiley in Pain Practice
- Vol. 25 (8) , e70086
Migration of a Dorsal Root Ganglion Stimulation Electrode Into the Mediastinum: A Clinical Case Study
Introduction: Dorsal root ganglion stimulation (DRGS) is a recognized treatment for chronic neuropathic pain. A well‐known complication is electrode migration, which most commonly occurs in a caudal direction. Objective: To present a rare clinical case of cranial migration of a DRGS electrode into the mediastinum. Case Presentation: A 62‐year‐old woman with pharmacoresistant intercostal neuralgia underwent DRGS electrode implantation at the Th2 level using a standard linear lead, as specialized DRGS electrodes were unavailable. Initial therapy was effective. However, follow‐up imaging approximately two years post implantation revealed that the electrode had migrated cranially through the Th2‐Th3 intervertebral foramen. The tip was located in the mediastinum, in immediate proximity to the right subclavian artery, creating a significant risk of vascular or pleural injury. The electrode was successfully and safely explanted. Conclusion: This is the first reported case of mediastinal migration of a DRGS electrode. It highlights the unique risks associated with off‐label cranial DRGS applications due to anatomical constraints and gravitational forces. The case underscores the urgent need for the development and use of specialized electrodes designed for such locations and reinforces the importance of improved fixation techniques and long‐term postoperative vigilance to mitigate migration risks.
- 15 October 2025
- Published by Wiley in Pain Practice
- Vol. 25 (8) , e70086
Migration of a Dorsal Root Ganglion Stimulation Electrode Into the Mediastinum: A Clinical Case Study
Introduction: Dorsal root ganglion stimulation (DRGS) is a recognized treatment for chronic neuropathic pain. A well‐known complication is electrode migration, which most commonly occurs in a caudal direction. Objective: To present a rare clinical case of cranial migration of a DRGS electrode into the mediastinum. Case Presentation: A 62‐year‐old woman with pharmacoresistant intercostal neuralgia underwent DRGS electrode implantation at the Th2 level using a standard linear lead, as specialized DRGS electrodes were unavailable. Initial therapy was effective. However, follow‐up imaging approximately two years post implantation revealed that the electrode had migrated cranially through the Th2‐Th3 intervertebral foramen. The tip was located in the mediastinum, in immediate proximity to the right subclavian artery, creating a significant risk of vascular or pleural injury. The electrode was successfully and safely explanted. Conclusion: This is the first reported case of mediastinal migration of a DRGS electrode. It highlights the unique risks associated with off‐label cranial DRGS applications due to anatomical constraints and gravitational forces. The case underscores the urgent need for the development and use of specialized electrodes designed for such locations and reinforces the importance of improved fixation techniques and long‐term postoperative vigilance to mitigate migration risks.
- Open Access
- 10 October 2025
- Published by ECO-Vector LLC (Publications) in Annals of Clinical and Experimental Neurology
- Vol. 19 (3) , 100-104
Combined spinal cord and peripheral nerve stimulation in severe neuropathic pain syndrome
Introduction. Chronic severe neuropathic pain syndrome (NPS) refractory to conservative and surgical treatments remains a significant clinical challenge. Chronic electrical stimulation of a single neural structure often proves insufficiently effective, highlighting the need for innovative approaches such as combined neuromodulation. This article aims to present a clinical case of combined spinal cord and peripheral nerve stimulation. A case report. A 32-year-old female with iatrogenic injury to the sural nerve following surgical intervention presented with refractory NPS (8 points on VAS). Failed conservative therapy (gabapentin, duloxetine) and surgical management (neuroma excision) led to chronic spinal cord stimulation, achieving 30% pain reduction. Subsequent ultrasound-guided peripheral nerve electrode implantation combined with chronic electrical stimulation resulted in complete pain area coverage and pain intensity reduction to 1–2 points on VAS. Conclusion. Technical challenges associated with combined neuromodulation should not preclude its clinical application. Electrode proximity does not significantly affect system performance. Combined neuromodulation demonstrated synergistic effects in pain management by enhancing analgesia through simultaneous modulation of central and peripheral pain mechanisms. Large-scale studies evaluating the safety and efficacy of this combined approach are required for routine clinical implementation.
- 10 October 2025
- Published by ECO-Vector LLC (Publications) in Annals of Clinical and Experimental Neurology
- Vol. 19 (3) , 100-104
Open AccessCombined spinal cord and peripheral nerve stimulation in severe neuropathic pain syndrome
Introduction. Chronic severe neuropathic pain syndrome (NPS) refractory to conservative and surgical treatments remains a significant clinical challenge. Chronic electrical stimulation of a single neural structure often proves insufficiently effective, highlighting the need for innovative approaches such as combined neuromodulation. This article aims to present a clinical case of combined spinal cord and peripheral nerve stimulation. A case report. A 32-year-old female with iatrogenic injury to the sural nerve following surgical intervention presented with refractory NPS (8 points on VAS). Failed conservative therapy (gabapentin, duloxetine) and surgical management (neuroma excision) led to chronic spinal cord stimulation, achieving 30% pain reduction. Subsequent ultrasound-guided peripheral nerve electrode implantation combined with chronic electrical stimulation resulted in complete pain area coverage and pain intensity reduction to 1–2 points on VAS. Conclusion. Technical challenges associated with combined neuromodulation should not preclude its clinical application. Electrode proximity does not significantly affect system performance. Combined neuromodulation demonstrated synergistic effects in pain management by enhancing analgesia through simultaneous modulation of central and peripheral pain mechanisms. Large-scale studies evaluating the safety and efficacy of this combined approach are required for routine clinical implementation.
- 27 June 2024
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 6,p. 784-795
Augmented reality in neurosurger y: application and limitations. A literature review
Detection of surgical pathology is one of the primary tasks of a neurosurgeon, forming the basis of a topical diagnosis. In addition to the generally accepted neuronavigation using special navigation systems, establishing the localization of lesions in the brain and spinal cord can be achieved by integrating virtual information into the physically surrounding space of the operator, which is implemented in augmented reality (AR). This article reviews the history of the development of this technology and its application in neurosurgery and analyzes the results of using AR not only in the context of clinical neurosurgical practice, but also during the educational process, improving manipulation skills and studying neuroanatomy. The review analyzes the experience of researchers who have applied the AR method in various branches of neurosurgery, such as vascular, functional, and spinal neurosurgery and neuro-oncology, characterizes the accuracy of this method compared with frameless neuronavigation systems, and considers current prospects for future development in this area. Despite the increasing interest of the neurosurgical community in this technology and all the benefits it can potentially bring to the surgical process, its use in routine practice, both clinical and educational, is still associated with certain limitations and difficulties, and this article presents possible ways to solve this problem.
- 27 June 2024
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 6,p. 784-795
Augmented reality in neurosurger y: application and limitations. A literature review
Detection of surgical pathology is one of the primary tasks of a neurosurgeon, forming the basis of a topical diagnosis. In addition to the generally accepted neuronavigation using special navigation systems, establishing the localization of lesions in the brain and spinal cord can be achieved by integrating virtual information into the physically surrounding space of the operator, which is implemented in augmented reality (AR). This article reviews the history of the development of this technology and its application in neurosurgery and analyzes the results of using AR not only in the context of clinical neurosurgical practice, but also during the educational process, improving manipulation skills and studying neuroanatomy. The review analyzes the experience of researchers who have applied the AR method in various branches of neurosurgery, such as vascular, functional, and spinal neurosurgery and neuro-oncology, characterizes the accuracy of this method compared with frameless neuronavigation systems, and considers current prospects for future development in this area. Despite the increasing interest of the neurosurgical community in this technology and all the benefits it can potentially bring to the surgical process, its use in routine practice, both clinical and educational, is still associated with certain limitations and difficulties, and this article presents possible ways to solve this problem.
- 23 April 2024
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 88 (6) , 5-12
Current state of algology — pain medicine — in the Russian Federation
Objective. To analyze the structure of care for patients with pain syndromes in the Russian Federation and possible improvement of these approaches. Material and methods. A detailed questionnaire was sent to 60 pain clinics. We received responses from 40 hospitals. Other information was obtained from annual statistical reports for 2021—2023. Fifteen clinics and departments in different regions were inspected. Results. A total of 3871 implantations of test electrodes and 2317 systems for permanent neurostimulation were performed in the Russian Federation in 2021—2023. There were 30—110 annual implantations in Moscow and St. Petersburg clinics, as well as 5—30 procedures in other hospitals. The indications for stimulation system implantation were persistent back pain syndrome (58%), complex regional pain syndrome (12.5%), spasticity (9%), chronic pelvic pain (7.5%), critical lower limb ischemia (6%), peripheral neuropathies (5%), refractory angina (1%), etc. (1%). About 3700 patients seek treatment in pain departments and clinics annually. Of these, 49% were referred for interventional treatment (blockades, radiofrequency ablation), 7% — for neuromodulation. Discussion. Extrapolation of the International Association for the Study of Pain (IASP) data suggests that 548.000 people in the Russian Federation suffer from neuropathic pain refractory to drug therapy. The need for pain surgery is 27.400 interventions per year. In the Russian Federation, there is no multiple-level medical care for severe pain syndromes. It is difficult to realize a comprehensive interdisciplinary approach to diagnosis, treatment and rehabilitation of patients who suffer and often become disabled only because of severe chronic pain. Conclusion. It is necessary to distinguish algology as a separate specialty and contribute to development of this extremely important area of medicine.
- 23 April 2024
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 88 (6) , 5-12
Current state of algology — pain medicine — in the Russian Federation
Objective. To analyze the structure of care for patients with pain syndromes in the Russian Federation and possible improvement of these approaches. Material and methods. A detailed questionnaire was sent to 60 pain clinics. We received responses from 40 hospitals. Other information was obtained from annual statistical reports for 2021—2023. Fifteen clinics and departments in different regions were inspected. Results. A total of 3871 implantations of test electrodes and 2317 systems for permanent neurostimulation were performed in the Russian Federation in 2021—2023. There were 30—110 annual implantations in Moscow and St. Petersburg clinics, as well as 5—30 procedures in other hospitals. The indications for stimulation system implantation were persistent back pain syndrome (58%), complex regional pain syndrome (12.5%), spasticity (9%), chronic pelvic pain (7.5%), critical lower limb ischemia (6%), peripheral neuropathies (5%), refractory angina (1%), etc. (1%). About 3700 patients seek treatment in pain departments and clinics annually. Of these, 49% were referred for interventional treatment (blockades, radiofrequency ablation), 7% — for neuromodulation. Discussion. Extrapolation of the International Association for the Study of Pain (IASP) data suggests that 548.000 people in the Russian Federation suffer from neuropathic pain refractory to drug therapy. The need for pain surgery is 27.400 interventions per year. In the Russian Federation, there is no multiple-level medical care for severe pain syndromes. It is difficult to realize a comprehensive interdisciplinary approach to diagnosis, treatment and rehabilitation of patients who suffer and often become disabled only because of severe chronic pain. Conclusion. It is necessary to distinguish algology as a separate specialty and contribute to development of this extremely important area of medicine.
- 11 March 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (2) , 154-157
Neurosurgical treatment of postherpetic neuralgia
Postherpetic neuralgia is a chronic and debilitating condition that can occur following an episode of herpes zoster (shingles). It is characterized by severe, persistent pain in the area where the shingles rash occurred. While various treatment approaches exist, including medications and non-invasive therapies, some cases of postherpetic neuralgia may require neurosurgical intervention. Neurosurgical treatment options for postherpetic neuralgia aim to alleviate the pain by targeting the affected nerves or neural pathways. One common approach is spinal cord stimulation (SCS). In SCS, electrodes are implanted along the spinal cord, and electrical impulses are delivered to interfere with the transmission of pain signals. This technique can modulate pain perception and significantly reduce the intensity and frequency of postherpetic neuralgia symptoms. Neurosurgical treatment of postherpetic neuralgia is typically considered when conservative measures have failed to provide sufficient relief. However, it is crucial for patients to undergo a comprehensive evaluation and consultation with a neurosurgeon to determine the most appropriate treatment approach based on their specific condition and medical history. The risks, benefits, and potential outcomes of neurosurgical interventions should be carefully discussed between the patient and their healthcare provider to make an informed decision.
- 11 March 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (2) , 154-157
Neurosurgical treatment of postherpetic neuralgia
Postherpetic neuralgia is a chronic and debilitating condition that can occur following an episode of herpes zoster (shingles). It is characterized by severe, persistent pain in the area where the shingles rash occurred. While various treatment approaches exist, including medications and non-invasive therapies, some cases of postherpetic neuralgia may require neurosurgical intervention. Neurosurgical treatment options for postherpetic neuralgia aim to alleviate the pain by targeting the affected nerves or neural pathways. One common approach is spinal cord stimulation (SCS). In SCS, electrodes are implanted along the spinal cord, and electrical impulses are delivered to interfere with the transmission of pain signals. This technique can modulate pain perception and significantly reduce the intensity and frequency of postherpetic neuralgia symptoms. Neurosurgical treatment of postherpetic neuralgia is typically considered when conservative measures have failed to provide sufficient relief. However, it is crucial for patients to undergo a comprehensive evaluation and consultation with a neurosurgeon to determine the most appropriate treatment approach based on their specific condition and medical history. The risks, benefits, and potential outcomes of neurosurgical interventions should be carefully discussed between the patient and their healthcare provider to make an informed decision.